Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Bath & Body Works ( (BBWI) ) has issued an announcement.
On May 29, 2025, Bath & Body Works reported a 2.9% increase in net sales to $1.4 billion for the first quarter of 2025, with earnings per diluted share rising 29% to $0.49, surpassing expectations. The company maintained its full-year 2025 guidance of 1% to 3% net sales growth and earnings per diluted share between $3.25 and $3.60. The announcement also highlighted the appointment of Daniel Heaf as CEO, effective May 16, 2025, signaling a strategic focus on growth in the home fragrance and beauty categories.
The most recent analyst rating on (BBWI) stock is a Hold with a $35.00 price target. To see the full list of analyst forecasts on Bath & Body Works stock, see the BBWI Stock Forecast page.
Spark’s Take on BBWI Stock
According to Spark, TipRanks’ AI Analyst, BBWI is a Neutral.
The overall score reflects significant financial challenges due to high leverage and negative equity, offset by attractive valuation and positive corporate developments. Technical indicators suggest moderate bullish momentum, while recent earnings call and corporate events provide a mixed but optimistic outlook.
To see Spark’s full report on BBWI stock, click here.
More about Bath & Body Works
Bath & Body Works is a global leader in personal care and home fragrance, offering products such as fine fragrance mist, body lotion and cream, 3-wick candles, home fragrance diffusers, and liquid hand soap. The company operates primarily in the U.S. and Canada with 1,900 locations, 524 international franchises, and an online store.
Average Trading Volume: 5,744,250
Technical Sentiment Signal: Sell
Current Market Cap: $6.51B
For detailed information about BBWI stock, go to TipRanks’ Stock Analysis page.